临床资料

例数(n)

MCT1 (低)

MCT1 (高)

P

MCT4 (低)

MCT4 (高)

P

性别

0.38

0.22

男

41 (54.7%)

25 (60.9%)

16 (39.1%)

27 (65.9%)

14 (34.1%)

女

34 (45.3%)

22 (64.7%)

12 (35.3%)

23 (67.6%)

11 (32.4%)

年龄(年)

56.5 ± 10

55.7 ± 9.7

57.7 ± 10.6

0.46

56.1 ± 8.6

56.9 ± 11.5

0.76

肿瘤直径(cm)

10.4 ± 3.3

9.6 ± 2.8

11.8 ± 3.7

0.22

9.7 ± 2.7

11.2 ± 3.7

0.11

T

0.35

0.95

T1

0

0

0

0

0

T2

0

0

0

0

0

T3

8 (10.7%)

6 (75.0%)

2 (25.0%)

4 (50.0%)

4 (50.0%)

T4

67 (89.3%)

45 (67.1%)

22 (32.9%)

34 (50.7%)

33 (49.3%)

N

0.89

0.47

N0

18 (24%)

12 (66.7%)

6 (33.3%)

10 (55.6%)

8 (44.4)

N (1~2)

57 (76%)

33 (57.9%)

24 (42.1%)

4

4

M

0.24

0.70

M0

49 (65%)

31 (63.2%)

18 (36.8%)

25 (51.0%)

24 (49.0%)

M1

26 (35%)

12 (46.2%

14 (53.8%)

12 (46.2%)

14 (53.8%)

Furmann分级

0.69

0.17

1

3 (4%)

2 (66.7)

1 (33.3%)

1 (33.3%)

2 (66.7)

2

17 (23%)

12 (70.6%)

5 (29.4%)

7 (41.2%)

10 (58.8%)

3

55 (73%)

31 (56.3%)

24 (43.6%)

31 (56.4%)

24 (43.6%)

MSKCC评分

0.54

0.91

1

5 (7%)

3 (60.0%)

2 (40.0%)

3 (60.0%)

2 (40.0%)

2

15 (20%)

7 (46.7%)

8 (53.3%)

8 (53.3%)

7 (46.7%)

3

55 (73%)

14 (25.5%)

41 (74.5%)

28 (50.9%)

27 (49.1%)